Lan Cao

Vice President, Head of Oncology Cell Therapy Innovation at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

Christian Solano

District Sales Manager OTC

Contact Christian Solano

Pedro Carrijo

Sales Intelligence Analyst

Contact Pedro Carrijo

Andre Pexe

Representante de vendas

Contact Andre Pexe

John Derosa

Senior Quality Assurance Specialist-Compliance

Contact John Derosa

Kyle Kuhn

Senior Director, Externalization

Contact Kyle Kuhn

Paulo Rocca

Medical Risk Management & Governance Sr. Manager - SAM Area (South Cone, Andean, Mexico &CAC)

Contact Paulo Rocca

John Weil

Head of Epidemiology, Takeda Vaccines Business Unit .

Contact John Weil

View All Lan Cao's Colleagues
Lan Cao's Contact Details
HQ
224-554-6500
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Takeda Pharmaceuticals (formerly Nycomed)
Lan Cao's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about Lan Cao
Lan Cao currently works for Takeda Pharmaceuticals (formerly Nycomed).
Lan Cao's role at Takeda Pharmaceuticals (formerly Nycomed) is Vice President, Head of Oncology Cell Therapy Innovation.
Lan Cao's email address is ***@takeda.com. To view Lan Cao's full email address, please signup to ConnectPlex.
Lan Cao works in the Major Drugs industry.
Lan Cao's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Christian Solano, Pedro Carrijo, Andre Pexe, John Derosa, Kyle Kuhn, Paulo Rocca, John Weil and others.
Lan Cao's phone number is 224-554-6500
See more information about Lan Cao